MCID: CRN006
MIFTS: 32

Coronary Aneurysm

Categories: Cardiovascular diseases

Aliases & Classifications for Coronary Aneurysm

MalaCards integrated aliases for Coronary Aneurysm:

Name: Coronary Aneurysm 12 42 14 69
Arteriovenous Aneurysm of Coronary Vessels 12
Aneurysmal Lesion of Coronary Artery 12
Aneurysm of Coronary Vessels 12

Classifications:



External Ids:

Disease Ontology 12 DOID:3362
ICD10 33 I25.41
ICD9CM 35 414.11
MeSH 42 D003323
SNOMED-CT 64 373139003 50570003
UMLS 69 C0010051

Summaries for Coronary Aneurysm

MalaCards based summary : Coronary Aneurysm, also known as arteriovenous aneurysm of coronary vessels, is related to aneurysm and kawasaki disease. An important gene associated with Coronary Aneurysm is TET1 (Tet Methylcytosine Dioxygenase 1). The drugs Acetazolamide and Everolimus have been mentioned in the context of this disorder. Affiliated tissues include heart, brain and kidney.

Related Diseases for Coronary Aneurysm

Graphical network of the top 20 diseases related to Coronary Aneurysm:



Diseases related to Coronary Aneurysm

Symptoms & Phenotypes for Coronary Aneurysm

Drugs & Therapeutics for Coronary Aneurysm

Drugs for Coronary Aneurysm (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 173)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Acetazolamide Approved, Vet_approved Phase 4 59-66-5 1986
2
Everolimus Approved Phase 4,Phase 3,Phase 1,Phase 2 159351-69-6 6442177
3
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2 22916-47-8 4189
4
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 53123-88-9 5284616 6436030 46835353
5
Ticlopidine Approved Phase 4 55142-85-3 5472
6
Ramipril Approved Phase 4 87333-19-5 5362129
7
Valsartan Approved, Investigational Phase 4 137862-53-4 60846
8
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2 50-78-2 2244
9
Sufentanil Approved, Investigational Phase 4 56030-54-7 41693
10
Eplerenone Approved Phase 4 107724-20-9 150310 443872
11
Spironolactone Approved Phase 4 1952-01-7, 52-01-7 5833
12
Mannitol Approved, Investigational Phase 4 69-65-8 453 6251
13
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
14
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
15
Clopidogrel Approved, Nutraceutical Phase 4 120202-66-6, 113665-84-2 60606
16
Angiotensin II Investigational Phase 4,Phase 3 68521-88-0, 4474-91-3, 11128-99-7 172198 65143
17 Anticonvulsants Phase 4
18 Carbonic Anhydrase Inhibitors Phase 4
19 diuretics Phase 4
20 Natriuretic Agents Phase 4
21 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1
22 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 1,Phase 2
23 Antifungal Agents Phase 4,Phase 3,Phase 1,Phase 2
24 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1
25 Cytochrome P-450 Enzyme Inhibitors Phase 4
26 Fibrinolytic Agents Phase 4
27 Immunosuppressive Agents Phase 4,Phase 3,Phase 1,Phase 2
28 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
29 Platelet Aggregation Inhibitors Phase 4,Phase 3
30 Purinergic P2 Receptor Antagonists Phase 4
31 Purinergic P2Y Receptor Antagonists Phase 4
32 Angiotensin-Converting Enzyme Inhibitors Phase 4
33 Anticholesteremic Agents Phase 4,Phase 3,Phase 2
34 Antihypertensive Agents Phase 4,Phase 3,Phase 1,Early Phase 1
35 Antimetabolites Phase 4,Phase 3,Phase 2
36 Calcium, Dietary Phase 4,Phase 3,Phase 2
37 HIV Protease Inhibitors Phase 4,Phase 3
38 Hydroxymethylglutaryl-CoA Reductase Inhibitors Phase 4,Phase 3,Phase 2
39 Hypolipidemic Agents Phase 4,Phase 3,Phase 2
40 Lipid Regulating Agents Phase 4,Phase 3,Phase 2
41
protease inhibitors Phase 4,Phase 3
42 Rosuvastatin Calcium Phase 4 147098-20-2
43 Angiotensin II Type 1 Receptor Blockers Phase 4,Phase 3
44 Angiotensin Receptor Antagonists Phase 4,Phase 3
45 Angiotensinogen Phase 4,Phase 3
46 Analgesics Phase 4,Phase 2,Phase 3
47 Analgesics, Non-Narcotic Phase 4,Phase 2,Phase 3
48 Peripheral Nervous System Agents Phase 4,Phase 2,Phase 3,Early Phase 1
49 Anesthetics Phase 4,Phase 3,Phase 1
50 Anesthetics, General Phase 4,Phase 3

Interventional clinical trials:

(show top 50) (show all 231)

id Name Status NCT ID Phase Drugs
1 Effectiveness of Acetazolamide in Reducing Paralysis of the Leg in Patients Undergoing Aortic Aneurysm Surgery Surgery Unknown status NCT01889498 Phase 4 Acetazolamide
2 Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing Unknown status NCT00698607 Phase 4 6-month clopidogrel therapy;12-month clopidogrel therapy
3 Prophylactic Mesh Implantation After Abdominal Aortic Aneurysm Repair Unknown status NCT01353443 Phase 4
4 Statin and Angiotensin-converting Enzyme Inhibitor on Symptoms in Patients With SCAD Unknown status NCT02008786 Phase 4 ramipril;rosuvastatin;placebo
5 A Morbidity-Mortality and Remodeling Study With Valsartan Unknown status NCT00133328 Phase 4 valsartan
6 Trial to Assess the Efficacy of Combination Formula of Aspirin Plus Clopidogrel in Patients With Coronary Stent Completed NCT02410083 Phase 4 Clopirin 1;Clopidogrel-Aspirin(co-administration) 1;Clopirin 2;Clopidogrel-Aspirin(co-administration) 2
7 Prevalence of Abdominal Aortic Aneurysm in Patients Undergoing Coronary Angiography Completed NCT01239225 Phase 4
8 Randomized Trial of Pulsatile vs Non Pulsatile Perfusion on Short Term Changes in Kidney Function Using an Intra-Aortic Ballooon Pump During Cardioplegic Arrest in Patients Undergoing Myocardial Reperfusion Completed NCT00454428 Phase 4
9 The Pharmacokinetics of Opioids and Sedative/Hypnotics During Selective Cerebral Perfusion Completed NCT00494598 Phase 4 Sufentanil
10 XIENCE V: SPIRIT WOMEN Sub-study Completed NCT01182428 Phase 4
11 Add-on Effects of Valsartan on Morbi- Mortality (KYOTO HEART Study) Completed NCT00149227 Phase 4 Valsartan;Non-ARB
12 MAPS Trial: Matrix And Platinum Science Completed NCT00396981 Phase 4
13 Post-Approval Trial of the Talent™ Abdominal Stent Graft to Treat Aortic Aneurysms Completed NCT00816062 Phase 4
14 Eplerenone in the Management of Abdominal Aortic Aneurysms Recruiting NCT02345590 Phase 4 Eplerenone
15 CUstodiol Versus RInger: whaT Is the Best Agent? Active, not recruiting NCT02327611 Phase 4 Custodiol;Enriched Ringer's lactate solution
16 The (PIVOTAL) Study Terminated NCT00444821 Phase 4
17 Clinical Evaluation of a Modular Extracorporeal Circulation Circuit Unknown status NCT02000544 Phase 3
18 Transradial Versus Transulnar Artery Approach for Coronary Interventions Unknown status NCT01364532 Phase 3
19 Magnetic Resonance Imaging of Aortic Aneurysm Instability Unknown status NCT00794092 Phase 2, Phase 3 Sinerem administration
20 34mm Cuff Study for Endovascular Repair of Abdominal Aortic Aneurysms Unknown status NCT00706394 Phase 2, Phase 3
21 Trial of Pulse Steroid Therapy in Kawasaki Disease--Pediatric Heart Network Completed NCT00132080 Phase 3 Steroids
22 Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stents to Treat De Novo Coronary Lesions Completed NCT00301522 Phase 2, Phase 3
23 Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent Restenosis Completed NCT00287573 Phase 2, Phase 3
24 Melatonin and Cardiac Outcome After Major Surgery Completed NCT00315926 Phase 2, Phase 3 Melatonin;Placebo
25 Angio-Seal® vs. Exo-Seal® for Closure of Arterial Puncture Sites Completed NCT01669382 Phase 3
26 Conservative Aortic Valve Surgery for Aortic Insufficiency and Aneurysms of the Aortic Root. CAVIAAR Completed NCT00478803 Phase 3
27 VALOR: The Talent Thoracic Stent Graft System Clinical Study Completed NCT00604799 Phase 2, Phase 3
28 Curcumin to Prevent Complications After Elective Abdominal Aortic Aneurysm (AAA) Repair Completed NCT01225094 Phase 2, Phase 3 curcumin
29 SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS) Completed NCT00180479 Phase 3
30 SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System Completed NCT00180310 Phase 3
31 SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting Coronary Stent System Completed NCT00180453 Phase 3
32 ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary Stent System Clinical Investigation Completed NCT00300131 Phase 3
33 Esmolol Infusion in Patients Undergoing Craniotomy Completed NCT02455440 Phase 3 Esmolol;Placebo;Propofol and sevoflurane
34 RADIAL Versus Femoral Access for Coronary Artery Bypass Graft Angiography and Intervention (RADIAL-CABG) Trial Completed NCT01446263 Phase 3
35 Vitamin C for Prophylaxis of Post-operative Atrial Fibrillation in On-pump Cardiac Surgery Procedures Completed NCT01107730 Phase 3 Vitamin C;L-Carnitine;Placebo
36 Simvastatin in Aneurysmal Subarachnoid Haemorrhage (STASH) a Multicentre Randomised Controlled Clinical Trial Completed NCT00731627 Phase 3 placebo;simvastatin
37 Powerlink Bifurcated Stent Graft Long-Term Follow-up Study Completed NCT00543270 Phase 2, Phase 3
38 BioVentrix Revivent TC™ System Clinical Study Recruiting NCT02931240 Phase 2, Phase 3
39 Effect of Tranexamic Acid in Ruptured Abdominal Aortic Aneurysms Recruiting NCT02125890 Phase 3 Tranexamic Acid
40 Study of Aortic Root Reimplantation Procedure Recruiting NCT01787604 Phase 3
41 Evaluating the Effectiveness of Atorvastatin on the Progression of Aortic Dilatation and Valvular Degeneration in Patients With Bicuspid Aortic Valve Recruiting NCT02679261 Phase 3 Atorvastatin;Placebo
42 KIDCARE (Kawasaki Disease Comparative Effectiveness Trial) Recruiting NCT03065244 Phase 3 IVIG;Infliximab
43 Apixaban Versus Warfarin in Patients With Left Ventricular (LV) Thrombus Not yet recruiting NCT03232398 Phase 3 Apixaban Oral Tablet [Eliquis];Warfarin
44 Study of the Efficacy of Losartan on Aortic Dilatation in Patients With Marfan Syndrome Terminated NCT00763893 Phase 3 placebo;Losartan
45 Study to Demonstrate the Non-inferiority of Olmesartan Medoxomil Versus Candesartan Cilexetil in Reducing Blood B-type (or Brain) Natriuretic Peptide Levels at Week 24 Terminated NCT00679484 Phase 3 olmesartan medoxomil + candesartan cilexetil placebo;olmesartan medoxomil placebo + candesartan cilexetil
46 Trial of Atorvastatin on the Persistent Coronary Aneurysm in Children With Kawasaki Disease Unknown status NCT02114099 Phase 2 Atorvastatin
47 Abdominal Aortic/Aorto-Iliac Aneurysm Endoluminal Graft Study Unknown status NCT00549354 Phase 2
48 Suprarenal Proximal Cuff Study for Treatment of Abdominal Aortic Aneurysm Unknown status NCT00739401 Phase 2
49 Prevention of Coronary Aneurysms in Kawasaki Syndrome Completed NCT00000520 Phase 2 immunoglobulins, intravenous;aspirin
50 Pharmacokinetics of AP214 Acetate in Patients Undergoing Cardiac Surgery Completed NCT00903604 Phase 2 AP214;Placebo

Search NIH Clinical Center for Coronary Aneurysm

Cochrane evidence based reviews: coronary aneurysm

Genetic Tests for Coronary Aneurysm

Anatomical Context for Coronary Aneurysm

MalaCards organs/tissues related to Coronary Aneurysm:

39
Heart, Brain, Kidney, Testes, Pancreas, Lung, Neutrophil

Publications for Coronary Aneurysm

Articles related to Coronary Aneurysm:

(show top 50) (show all 281)
id Title Authors Year
1
Coronary Aneurysm Formation After Bioresorbable Vascular Scaffold Implantation Resulting in Acute Myocardial Infarction. ( 28512285 )
2017
2
Extraluminal Migration of a Drug-Eluting Stent Into a Thrombosed Coronary Aneurysm With Preserved Antegrade FlowA in the Right Coronary Artery. ( 28365264 )
2017
3
"Giant within a giant": a case of typical Kawasaki disease with a giant coronary aneurysm and a large coronary thrombus - a rare case report. ( 28835313 )
2017
4
Nationwide Survey of Patients With Giant Coronary Aneurysm Secondary to Kawasaki Disease 1999-2010 in Japan. ( 28855435 )
2017
5
Retrospective study of the impact of unrecognised Kawasaki disease, coronary aneurysm and ectasia. ( 28818354 )
2017
6
Mega-giant coronary aneurysm: antithrombotic therapy is an option. ( 28821483 )
2017
7
Lesion preparation with cutting balloon angioplasty is associated with coronary aneurysm formation in polylactide bioresorbable vascular scaffold implantation. ( 28760724 )
2017
8
Stenotic false lumen as inflow of coronary aneurysm and full-metal jacket. ( 28688710 )
2017
9
Long-Term Outcome of Kawasaki Disease Complicated by a Large Coronary Aneurysm. ( 28765734 )
2017
10
Angioscopic observation of an atherosclerotic coronary aneurysm without yellow plaque. ( 28739628 )
2017
11
Importance of detailed distribution of branches in giant coronary aneurysm. ( 28186232 )
2017
12
Coronary aneurysm formation following bare-metal stent implantation: an optical coherence tomography evaluation. ( 28102661 )
2017
13
Long-Term Prognosis for Patients with Kawasaki Disease Complicated by Large Coronary Aneurysm (diameter a8Y6 mm). ( 28765744 )
2017
14
Very Late Stent Migration Within a GiantA Coronary Aneurysm in a Patient WithA Kawasaki Disease: Assessment With Multidetector Computed Tomography. ( 28823775 )
2017
15
Giant coronary aneurysm management with Viabahn covered stent. ( 28483590 )
2017
16
Importance of detailed distribution of branches in giant coronary aneurysm. ( 27634923 )
2016
17
Corticosteroid Therapy Might be Associated with the Development of Coronary Aneurysm in Children with Kawasaki Disease. ( 27064036 )
2016
18
Coronary aneurysm without malapposition after bioresorbable vascular scaffold implantation. ( 27173862 )
2016
19
Bilateral coronary artery fistulas with a giant coronary aneurysm complicated by aneurysm rupture: A case report. ( 27861394 )
2016
20
Biovascular scaffolds and reversible coronary aneurysm. ( 27070996 )
2016
21
Coronary Stenosis Associated with a Giant Coronary Aneurysm. ( 26626563 )
2016
22
A Loeys-Dietz patient with a transatlantic odyssey: repeated aortic root surgery ending with a huge left main coronary aneurysm. ( 27624358 )
2016
23
Giant coronary aneurysm in a patient with non-ST myocardial infarction. ( 27044918 )
2016
24
An unexpected huge coronary aneurysm. ( 27753603 )
2016
25
ST-elevation myocardial infarction in a young adult secondary to giant coronary aneurysm thrombosis: an important sequela of Kawasaki disease and a management challenge. ( 26791126 )
2016
26
A 5-year-old boy with only fever and giant coronary aneurysms: the enigma of Kawasaki disease? ( 27154559 )
2016
27
Multiple coronary aneurysms in a young adult with acquired immunodeficiency syndrome. ( 27168940 )
2016
28
Giant Coronary Aneurysms in a one-month-old Infant with Kawasaki Disease. ( 27641973 )
2016
29
Massive left main coronary aneurysm presenting as trepopnoea. ( 27594368 )
2016
30
A giant coronary aneurysm formed after coronary artery bypass grafting. ( 25634861 )
2015
31
Giant coronary aneurysm diagnosed as incidental mediastinal mass. ( 25616825 )
2015
32
Giant coronary aneurysm secondary to coronary-atrial fistula. ( 25660938 )
2015
33
A giant coronary aneurysm on the right coronary artery in a 16-year-old patient. ( 26574772 )
2015
34
Surgical Resection of a Giant Coronary Aneurysm. ( 26046882 )
2015
35
Recurrent Myocardial Infarctions Due toA Thrombosis of a Coronary Aneurysm inA Neurofibromatosis Type 1: Is Antiplatelet Treatment Enough? ( 25819181 )
2015
36
Multimodality Imaging of Giant Right Coronary Aneurysm and Postsurgical Coronary Artery Inflammation. ( 26149430 )
2015
37
Acute Myocardial Infarction That Resulted From Poor Adherence to Medical Treatment for Giant Coronary Aneurysm. ( 26155999 )
2015
38
Coronary Aneurysm and Stent Fracture Following Stenting of a Myocaridal Bridge. ( 25573225 )
2015
39
Intracoronary blood sampling with a microcatheter for the diagnosis of giant infective coronary aneurysm: Melioidosis of coronary artery mycotic aneurysm. ( 25863294 )
2015
40
Managing bioabsorbable vascular scaffold failure: combined scaffold restenosis and late-acquired coronary aneurysm treated with self-expandable stent. ( 25936494 )
2015
41
Giant coronary aneurysm caused by Kawasaki disease: consistency between catheter angiography and electrocardiogram gated dual-source computed tomography angiography. ( 26770226 )
2015
42
Giant right coronary aneurysm untreatable by percutaneous intervention. ( 26481179 )
2015
43
Coronary Aneurysm Closure With Pericardial Covered Stent Evaluated With Optical Coherence Tomography. ( 24954441 )
2014
44
Coronary steal due to ruptured right coronary aneurysm causing myocardial infarction in a patient with systemic lupus erythematosus. ( 25276619 )
2014
45
A Case of Kawasaki Disease with Coronary Aneurysm Responding to the 4th IVIG Treatment. ( 25161773 )
2014
46
Coronary Aneurysm After Paclitaxel-eluting Balloon Angioplasty. ( 24841291 )
2014
47
Coronary aneurysm with stent dislocation leading to the diagnosis of Marfan syndrome. ( 24778122 )
2014
48
Double giant coronary aneurysm: improved morphological study by computed tomography. ( 25006213 )
2014
49
Giant coronary aneurysm and arterial tortuosity. ( 25242352 )
2014
50
Coronary aneurysm mimicking a five chamber heart. ( 23733440 )
2014

Variations for Coronary Aneurysm

Expression for Coronary Aneurysm

Search GEO for disease gene expression data for Coronary Aneurysm.

Pathways for Coronary Aneurysm

GO Terms for Coronary Aneurysm

Sources for Coronary Aneurysm

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....